Skip to main content

Table 2 Biomarker serum levels

From: Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study

Ā 

At-risk women without PE

At-risk women with PE

p-value

n

119

32

Ā 

Biomarker Levels

ā€ƒGlyFn (Ī¼g/mL)

233 (92)

457 (206)

<ā€‰0.001

ā€ƒPAPPA2 (ng/mL)

72 (130)

505 (330)

<ā€‰0.001

ā€ƒPlGF (pg/mL)

275 (308)

40 (57)

<ā€‰0.001

ā€ƒsFlt-1 (ng/mL)

2186 (2170)

9869 (6613)

<ā€‰0.001

  1. Data are displayed as median (IQR). Biomarker distributions are compared via Wilcoxon rank sum test
  2. GlyFn glycosylated fibronectin, PAPPA2 pregnancy-associated plasma protein-A2, PlGF placental growth factor, sFlt-1 soluble fms-like tyrosine kinase-1